the market?
Illumina
NASDAQ: ILMN
70.13
-0.95
(-1.34%)
| Today's Open | $70.39 |
|---|---|
| Previous Close | $71.08 |
| Daily Range | $69.81 - $70.78 |
| 52-Week Range | $37.77 - $77.11 |
| Market Cap | $8.7B |
| P/E Ratio | 94.77 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 250,294 |
| Average Daily Volume | 1,759,286 |
| Current FY EPS | $1.60 |
How do you think ILMN
will perform against the market?
Top ILMN Bull/Bear Pitches
RedDave (< 20)
Submitted
January 26, 2011
Illumina has a technical lead making it the sequencing "Rule Maker" in this industry. The main competitors are Roche/454 and Life Sciences/SOLiD. 454 still has a nice technology and is quite complim … More
proisback (< 20)
Submitted
October 5, 2009
The PE is well into the nose bleed zone, while insider are very active sellers. Any slight misses or advances by competitors will cause decent size decline.
News & Commentary
The 3 Deadliest Diseases in the U.S.
These deadly diseases kill more than 1 million Americans every year. But there's still some good news.The Hidden Opportunity of the Novel Coronavirus
With the potential for an epidemic at hand, we look at things from a glass-half-full perspective.Is Illumina's Stock Destined for Greatness?
Let's see what the numbers say about Illumina (ILMN).Sector
Healthcare
Industry
Drugs
Illumina (ILMN) Description
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website: http://www.illumina.com/
CEO Rating by Glassdoor
More details for Illumina Jobs
Illumina reviews from employees
